CTOs on the Move

NeuBase Therapeutics

www.neubasetherapeutics.com

 
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Anthony Rossomando
 Chief Technology Officer Profile

Similar Companies

Somerset Pharma

COMPASS Pathways

COMPASS is a mental health care company dedicated to accelerating patient access and experience to evidence-based innovation in mental health care.

Apnimed

Apnimed is a clinical-stage company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders.

Biochemics Inc

Biochemics Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Sunrise Pharmaceutical Inc

Sunrise Pharmaceutical Inc is a Rahway, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.